2Flo Ventures

➡️ Health Equity Pitch Competition | Applications Close May 5th We have only a few weeks left to apply for 2Flo Ventures Health Equity Pitch Competition! Outside of the cash award, this is also a catalyst for emerging founders to get the support they need from a trusted community. In one week, we have had 40+ attendees offer various ways to support the finalists. This is in addition to access to 2Flo Ventures' 40+ advisors! Tag a founder who could use: Fundraising Strategy Advice Pitch Presentation Feedback Product Feedback Leadership Coaching Legal Support Market Research Consulting Strategy Consulting Website Design Feedback Business Development Support And more! ➡️ Link to application: https://lnkd.in/gwjxTVWi Apply Today! #HealthEquity

➡️ Health Equity Pitch Competition | Applications Close May 5th We have only a few weeks left to apply for 2Flo Ventures Health Equity Pitch Competition! Outside of the cash award, this is also a catalyst for emerging founders to get the support they need from a trusted community. In one week, we have had 40+ attendees offer various ways to support the finalists. This is in addition to access to 2Flo Ventures' 40+ advisors! Tag a founder who could use: Fundraising Strategy Advice Pitch Presentation Feedback Product Feedback Leadership Coaching Legal Support Market Research Consulting Strategy Consulting Website Design Feedback Business Development Support And more! ➡️ Link to application: https://lnkd.in/gwjxTVWi Apply Today! #HealthEquity

📣 2Flo Ventures 2nd Annual Health Equity Pitch Competition 📣 Please help us in supporting new innovations and solutions for advancing health equity! We are excited to continue supporting early-stage innovators with novel ideas for improving the health of their communities. The pitch competition will be held on the evening of May 14th and will followed by a world-class fireside chat! ➡️ Apply today: https://lnkd.in/gwjxTVWi In addition to the monetary support, we hope to provide a community of collaboration. In addition to accessing the experts and advisors at 2Flo Ventures, we support the facilitation of connecting with the registrants in attendance. Last year, we had over 80 people share ways they could help the finalist! Interested in attending to support health equity? Register here to attend: https://lu.ma/7z41b3i0 Best of luck to the founders - we can't wait to hear from you! For more information on the competition, visit https://lnkd.in/gV_yDmbn Thank you to Cushman & Wakefield for providing a beautiful penthouse venue for this event! #HealthEquity

📣 2Flo Ventures 2nd Annual Health Equity Pitch Competition 📣 Please help us in supporting new innovations and solutions for advancing health equity! We are excited to continue supporting early-stage innovators with novel ideas for improving the health of their communities. The pitch competition will be held on the evening of May 14th and will followed by a world-class fireside chat! ➡️ Apply today: https://lnkd.in/gwjxTVWi In addition to the monetary support, we hope to provide a community of collaboration. In addition to accessing the experts and advisors at 2Flo Ventures, we support the facilitation of connecting with the registrants in attendance. Last year, we had over 80 people share ways they could help the finalist! Interested in attending to support health equity? Register here to attend: https://lu.ma/7z41b3i0 Best of luck to the founders - we can't wait to hear from you! For more information on the competition, visit https://lnkd.in/gV_yDmbn Thank you to Cushman & Wakefield for providing a beautiful penthouse venue for this event! #HealthEquity

❤️ Innovation to Implementation of Equitable Healthcare Solutions ❤️ 2Flo Ventures Vice President Ibraheem Alinur will be speaking on the journey from promising healthcare innovations to widespread implementation, addressing funding challenges, collaboration opportunities, and strategies for scaling solutions to maximize patient impact. This will be a panel discussion alongside: Schnaude Dorizan, PhD | Venture Acceleration Manager, MATTER Andrew Zbihley | Co-Managing Director,. Nucelate Chicago Andrei Tadique, PMP | Head of Manufacturing Sciences, Takeda This session aims to provide valuable insights for founders, investors, and ecosystem partners working to advance healthcare innovation. Link to register: https://lnkd.in/e6h-YeH9

Jay Teamer is a PhD candidate in Pharmaceutical Sciences at UIC, specializing in biopolymer-based drug delivery for biofilm-infected wounds. Beyond the lab, he serves as Director of Program Management at Nucleate HQ and Due Diligence Lead at Nucleate Chicago, developing strategies to support early-stage biotech founders. With experience in ecosystem building, venture scouting, strategic operations, and organizational development, Jay is dedicated to fostering a more inclusive biotech landscape in the Midwest. For Jay, health equity means ensuring that life-changing innovations reach the people who need them most, not just those who can afford them. It's about allocating funding from saturated markets to solutions that serve underrepresented and often disregarded populations. He believes that real progress doesn't just happen; it's built with intention, by all of us, for all of us. By breaking down systemic barriers and supporting diverse founders with access to capital, mentorship, and resources, he is committed to driving real impactful change. At 2Flo Ventures, Jay is excited to explore investment opportunities that advance health equity, particularly in Black and Latino communities, where gaps in innovation and funding persist. Through his venture development and strategic operations work, he aims to help bridge these gaps, ensuring that biotech and healthcare innovations are groundbreaking but also accessible and impactful where they're needed most.

📣 Fellow Friday 📣 We're thrilled to have Rebecca Keate join us as a 2Flo Ventures' Fellow! With a Bachelor of Science in Biomedical Engineering from Georgia Tech and a PhD from Northwestern University, Rebecca has designed regenerative biomaterials and translated academic research into real-world impact. As a PhD student, she worked with Northwestern's Office of Innovation and New Ventures, gaining firsthand experience moving scientific discoveries toward commercialization. Now, as co-founder of Cellmend Technologies, a Northwestern spinout, Rebecca is developing infection prevention and detection products using a glowing molecule—a groundbreaking approach to improving patient outcomes. To Rebecca, health equity means thinking about populations experiencing daily health struggles that experience chronic neglect. By designing new technologies with individual differences in mind, we can ensure better health solutions that benefit all instead of only helping the most. She is passionate about innovation that enhances the quality of life for historically overlooked populations, which aligns perfectly with 2Flo's mission. During the fellowship, Rebecca looks forward to diving deeper into the cutting-edge innovations shaping human health. We're excited to see the impact she'll make! Join us in welcoming Rebecca to the 2Flo Ventures community!

We are excited to see Rod Cotton, Venture Partner at 2Flo Ventures, highlight new treatments for septic shock as an underserved market opportunity for pharmaceutical innovators in the latest Scrip Asks 2025 Therapeutic Area Advances column! Vivacelle Bio, Inc., a 2Flo Ventures portfolio company, is advancing its lead product, VBI-S, in a Phase 3 clinical trial for hypovolemic septic shock. The company is positioning its therapy as a potential near-to-market solution for a disease that claims more lives per year than cancer.   Read Rod’s comments as well as opinions from other pharmaceutical industry leaders in the full article, accessible here: https://lnkd.in/dSyX8Mmu #HealthEquity

Welcome, Raven Moten, to the 2Flo Ventures Team! We're excited to welcome Raven to 2Flo Ventures! As a PhD candidate in Genetics, Genomics, and Systems Biology at UChicago, Raven's research leverages sequencing technologies to uncover genomic regulation mechanisms—a foundation for groundbreaking biomedical innovations. Beyond the lab, Raven actively engages in the UChicago Biotechnology Association and Nucleate Chicago, fostering connections between science and entrepreneurship. For Raven, health equity means ensuring everyone has access to the care and resources they need, addressing systemic barriers, and uplifting diverse perspectives to create a more inclusive and effective healthcare system. At 2Flo, Raven looks forward to supporting entrepreneurs tackling unmet needs in underserved communities and strengthening ties within the Chicago biotech ecosystem. With expertise in critical thinking, data analysis, and project management, she is passionate about bridging the gap between cutting-edge research and real-world impact. Join us in welcoming Raven! We can't wait to see her contributions to 2Flo Ventures.

📣 Join us in welcoming Cristina Vaca to 2Flo Ventures! Cristina has been an outstanding 2Flo Ventures Fellow for the last five months! Cristina is a PhD Candidate at Northwestern University, where she studies immunology and infectious disease, focusing on developing cure strategies for HIV and boosting anti-viral host factors to prevent rebound infections. Beyond the lab, Cristina is the Director of Research at Nucleate Chicago, where she helps academics commercialize breakthrough technologies and launch biotech startups across the Midwest. She brings a keen eye for innovation and a deep commitment to health equity—ensuring that healthcare solutions are driven by patient needs. At 2Flo Ventures, Cristina is most excited to explore cutting-edge startups tackling health inequities, particularly in women’s health and at the intersection of biotechnology and sustainability. As she puts it: “Climate change is a health equity problem as well!” We can’t wait to see her impact on the venture ecosystem. 🚀